Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Canada
Pharma
Teva, Samsung Bioepis deepen biosimilar bonds with new deal
Already sharing the load on two biosimilar assets, Teva Pharmaceutical and Samsung Bioepis have elected to take their partnership to the next level.
Fraiser Kansteiner
Oct 2, 2026 10:00am
Alfasigma gains drug, new territories with M&A play
Aug 12, 2026 11:23am
Dr. Reddy's temporarily pauses generic semaglutide supplies
Jul 9, 2026 8:48am
Colorado wins FDA approval to import cheaper drugs from Canada
Jun 17, 2026 10:30am
Sanofi invests $294M to scale Toronto AI hub
May 5, 2026 9:21am
Delpharm snags Canadian investment to upgrade injectables plant
Mar 19, 2025 3:30pm
